Over-accessible chromatin links myeloma initiating genetic events to oncogenic transcriptomes and aberrant transcription factor regulatory networks
Alvarez-Benayas, J.; Katsarou, A.; Trasanidis, N.; Chaidos, A.; May, P. C.; Ponnusamy, K.; Xiao, X.; Bua, M.; Atta, M.; Roberts, I. A.; Auner, H. W.; Hatjiharissi, E.; Papaioannou, M.; Caputo, V. S.; Sudbery, I. M.; Karadimitris, A.
Show abstract
Multiple myeloma is a genetically heterogeneous cancer of the bone marrow plasma cells (PC). Myeloma initiating genetic events define subgroups (MIE) and drive distinct oncogenic transcriptomes that converge into a mutually exclusive overexpression of CCND1 and CCND2 oncogenes. Here, with reference to normal PC, we dissect how MIE impact the chromatin regulatory landscape of MM. We find that chromatin accessibility combined with transcriptome profiling classifies myeloma genetic subgroups, while in a topologically constrained manner, distal rather than proximal regulatory elements influence myeloma transcriptomes. Across and within MIE-defined subgroups, genes and pathways critical for myeloma biology can be linked to developmentally activated or de novo formed enhancers. We show that existing transcription factors, co-opted to organise highly ordered, aberrant regulatory networks, generate known and novel myeloma cell dependencies and help identify prognostic markers. Finally, we discover and functionally validate the critical enhancer that regulates ectopic expression of CCND2 in MM.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Aberrant non-canonical NF-kappaB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma 95%
- Genomic landscape and chronological reconstruction of driver events in multiple myeloma 95%
- Genetic Subtypes of Smoldering Multiple Myeloma are associated with Distinct Pathogenic Phenotypes and Clinical Outcomes 94%
Similar papers in this journal
Similar papers in this journal
- Systems medicine dissection of chromosome 1q amplification reveals oncogenic regulatory circuits and informs targeted therapy in cancer 95%
- Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression between patients 93%
- KDM6A Regulates Immune Response Genes in Multiple Myeloma 93%
Similar papers in this journal
- Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma 93%
- Medulloblastoma Group 3 and 4 Tumors Comprise a Clinically and Biologically Significant Expression Continuum Reflecting Human Cerebellar Development 93%
- Inhibition of mutant IDH1 promotes cycling of acute myeloid leukemia stem cells 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.